Blog

Fred’s January 10th Herd Immunity presentation to his Harvard Business School community


Timestamps are indicated by small blue circles on the video timeline. Click on the circle to go directly to that section of the video.

 

  • 00:00:10 Herd Immunity Overview – How is Herd Immunity Determined
  • 00:06:29  Why the EUA approved vaccines seem to be safe and promising – The Vaccines
  • 26:05:00 How the unknowns could impact herd immunity – Unknowns Remain
  • 26:37:00 Unknown: Transmission Reduction vs Symptom Reduction – Transmission – More Effacious than Symptomatic
  • 31:30:00 Unknown: Durability –  Durability: Only Time Will Tell
  • 32:47:00 Potential scenarios we face –  Achieving Herd Immunity – The Pathway
  • 38:31:00 Viral Mutations – Viral Mutations Adds Challenge to Herd Immunity
  • 54:30:00 AstroZeneca Clinical Trial results – Astra Zeneca Vaccine Approved
  • 01:08:50 The next few months – why NPI is critical – Viral Mutations Adds Challenge to Herd Immunity
  • 01:12:48 Vaccination implementation – the challenges – States have more responsibility than resources for last mile distribution
  • 01:15:43 Allocation Strategy – Vaccination Allocation Strategy
  • 01:18:56 Supply, demand and bottlenecks – Vaccination Bottlenecks
  • 01:32:40 Mobile units recommendation – Mobile Units Best Approach
  • 01:34:30 Vaccination resistance will impede for herd immunity – We are far short of the 85% population . .
  • 01:50:04 Best and worst case scenarios – 2021 Three US Scenarios
  • 01:56:44 Navigating the pre-herd immunity world – Pre-vaccine control multiples vaccine effectiveness and saves lives
  • 02:05:50 Big Pharma Winners – Pharma Winners
  • 02:13:56 Predictions and Outlook – Fred’s Predictions